We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
A Connection Between the Gut Microbiome and Epigenetic Modification in Age-Related Cancer: A Narrative Review
Summary
This review explores how age-related changes in the gut microbiome can influence cancer development through epigenetic modifications like DNA methylation and histone alterations. Researchers found that the gut microbiome plays a dual role, both protecting against and potentially contributing to cancer susceptibility as people age. The study suggests that targeted interventions to maintain a healthy gut microbiome could be a strategy for reducing age-related cancer risk.
As individuals age, physiological changes influence the composition and function of the gut microbiome, significantly impacting the onset and progression of various illnesses, including cancer. Notably, the gut microbiome affects epigenetic modifications such as DNA methylation and histone alterations. Furthermore, it contributes to the age-related decline in immune system efficiency, increasing susceptibility to infections and cancers. This dual role of the gut microbiome-both a protective factor and a risk factor-is a key aspect of its importance in maintaining long-term health, making it a significant topic of discussion in this review. Moreover, a challenge faced by the elderly is the concurrent use of multiple medications. Polypharmacy can interact with the gut microbiome, potentially altering its efficacy, leading to adverse drug reactions, and affecting vital microbiome diversity. The effects of these interactions on cancer therapies and the overall health of elderly patients are becoming increasingly important. Understanding the complex relationship between aging, the gut microbiome, cancer, and polypharmacy is crucial for developing more effective therapeutic strategies and improving patient outcomes. Here, we discuss recent advances in understanding age-related physiological changes in the microbiome and their significance in cancer development and therapy. Specifically, we will explor how epigenetic changes acquired during aging, along with ongoing prescriptions of multiple medications and the decline of immune function, contribute to the intricate relationship between aging and cancer.
Sign in to start a discussion.
More Papers Like This
Epigenetic Mechanisms in Aging: Extrinsic Factors and Gut Microbiome
This review explores how external environmental factors and the gut microbiome influence epigenetic changes associated with aging. Researchers found that gut bacteria can modify host gene expression through histone and DNA modifications, with microbial metabolites playing an underexplored role. The study highlights the need for further research into how environmental exposures, including pollutants, may affect aging through gut-mediated epigenetic mechanisms.
Gut microbiota: an ideal biomarker and intervention strategy for aging
Not relevant to microplastics — this review explores how gut microbiome composition can serve as a biomarker for aging and a target for anti-aging interventions in humans, without addressing plastic pollution.
Microplastics: An emerging environmental risk factor for gut microbiota dysbiosis and cancer development?
This review examines how microplastics may disrupt the gut microbiome and immune system in ways that could promote cancer development. Evidence from recent studies suggests microplastics can cause chronic inflammation, alter the balance of gut bacteria, and trigger molecular pathways linked to several cancer types including lung, liver, breast, and colon cancer. While more human research is needed, the review highlights a concerning connection between microplastic exposure, gut health, and cancer risk.
Why Is Colorectal Cancer Occurring Earlier? Metabolic Dysfunction, Underrecognized Carcinogens, and Emerging Controversies
Researchers reviewed the rising incidence of early-onset colorectal cancer in people under 50, synthesizing epidemiological, molecular, and multi-omics evidence that implicates metabolic dysfunction, accelerated epigenetic aging, gut microbiome dysbiosis, and modern environmental exposures including micro- and nanoplastics as converging contributors to this trend.
The Impact of the Gut Microbiome, Environment, and Diet in Early-Onset Colorectal Cancer Development
This review explores why colorectal cancer is increasing among younger people, pointing to changes in gut bacteria, diet, and environmental exposures as likely contributors. Microplastics are discussed as one of several environmental factors that may be disrupting the gut microbiome and promoting inflammation linked to cancer development. The findings suggest that the rising tide of environmental contaminants, including microplastics, could be playing a role in this troubling health trend.